Home Cart Sign in  
Chemical Structure| 3717-88-2 Chemical Structure| 3717-88-2

Structure of Flavoxate HCl
CAS No.: 3717-88-2

Chemical Structure| 3717-88-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Flavoxate HCl is a competitive AChR antagonist with IC50 of 12.2 μM, used as a muscle relaxant.

Synonyms: Rec-7-0040; DW61; Flavoxate HCl, Flavoxate hydrochloride, DW-61, Rec-7-0040

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Flavoxate HCl

CAS No. :3717-88-2
Formula : C24H26ClNO4
M.W : 427.92
SMILES Code : O=C(C1=C2C(C(C(C)=C(C3=CC=CC=C3)O2)=O)=CC=C1)OCCN4CCCCC4.Cl
Synonyms :
Rec-7-0040; DW61; Flavoxate HCl, Flavoxate hydrochloride, DW-61, Rec-7-0040
MDL No. :MFCD00072099

Safety of Flavoxate HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • mAChR

    mAChR, IC50:12.2 μM

In Vitro:

Cell Line
Concentration Treated Time Description References
human detrusor myocytes 10 μM To investigate the effects of Flavoxate on voltage-dependent Ba2+ inward currents, results showed Flavoxate inhibited the peak amplitude in a voltage- and concentration-dependent manner PMC1576239
PC12 cells 100 μM 30 min To investigate the inhibitory effect of Flavoxate on calcium channels in PC12 cells and its impact on cytotoxicity and apoptosis. Results showed that Flavoxate pretreatment increased cytotoxicity and apoptotic index, and reduced neurite outgrowth compared to the control group. PMC4362412

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00440739 Pain Phase 4 Completed - Thailand ... More >> Faculty of Medicine Siriraj Hospital, Mahidol University Bangkok, Thailand, 10700 Less <<
NCT00992238 Healthy Phase 1 Completed - United States, North Dakota ... More >> PRACS Institute, Ltd Fargo, North Dakota, United States, 58104 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.34mL

0.47mL

0.23mL

11.68mL

2.34mL

1.17mL

23.37mL

4.67mL

2.34mL

References

 

Historical Records

Categories